Search

everythinglearnresearchcommunity

for

Search:↓

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Terbinafine quickly builds up in skin and hair, staying effective for over 3 weeks.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

The minoxidil and finasteride foam remains stable and effective for 180 days at room temperature.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Calancardin B may help reduce inflammation in immune cells.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Flavin prevents cataracts in young rats.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Folliculitis decalvans and tufted folliculitis are related, and a new treatment with rifampicin and clindamycin is effective.

The article's findings are uncertain and should be viewed with caution.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

The fibroin-based formulation strengthens and repairs chemically damaged hair.

The formulated gel is a promising treatment for alopecia areata.

Finasteride may reduce prostate cancer risk.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Metformin and clomiphene citrate together improve pregnancy chances and reduce miscarriages in women with PCOS.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

The method accurately measures finasteride in skin after using special carriers.

Crushed finasteride tablets can harm pregnant and fertile women.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

The hydrogel with Finasteride provides controlled, sustained drug release and improved bioavailability.